3D Cell Culture – London – 20-21 Feb 2019
SMi’s 3rd Annual Conference 3D Cell Culture February 20-21, 2019 | London, United Kingdom ————————————————————————- Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional… Read more »
Advanced Cell Culture: A Practical Approach – London – 8th June
Ann Kramer will present at the ECACC workshop Advanced Cell Culture: A Practical Approach on 8th June on the use of electrospun scaffolds in phenotypically relevant assays. Stephen Jones will be present at the exhibition stand to answer questions. A one day workshop in London, UK – Friday 8th June 2018 ECACC is excited to… Read more »
Bio – Boston – 4-7 June
Dr Kitty Lawton will attend the Bio convention in Boston from 4-7 June 2018.
Advances in Cell and Tissue Culture – Cardiff – 22 May 2018
Stephen Jones will present a poster at Advances in Cell and Tissue Culture in Cardiff on 22 May. Dr Gary Allenby of Aurelia Biosciences will present on novel assay approaches using Mimetix microscaffolds that has been developed jointly by Aurelia and The Electrospinning Company.
UCL Innovation Forum – London – 24th April 2018
TECL’s CEO Ann Kramer will be speaking at this year’s Innovation Forum event on Regenerative Medicine. A new era in Regenerative Medicine: accelerating research from bench to bedside. You can register here. About the event Stem Cell Therapies, CAR-T, Cell and Gene Therapies, are the cutting-edge technologies of translational medicine in the 21st century. They… Read more »
Biotrinity – London – April 24th 2018
BioTrinity is Europe’s Leading Biopartnering and Investment Conference and is in London from April 23-25 2018 Ann Kramer will be on a panel ‘The Future of Medical 3D Printing’ session at BioTrinity 2018, that is taking place on Tuesday, 24 April at 13:40 – 14:30.
Stem cell culture in coated scaffolds
A simple 3-D culture system, made of electrospun polycaprolactone (PCL) fibers and coated with defined extracellular proteins that occur naturally in the stem cell niche, allowed dispersed attachment and culture of human pluripotent stem cells devoid of cell aggregation. A publication from The Royal Institute of Technology (KTH), Stockholm describes how PCL fiber scaffolds coated… Read more »
KTP award for smart biomaterial development
The Electrospinning Company and the University of Nottingham have been awarded a Knowledge Transfer Partnership project to develop thermo-responsive scaffolds for 3D cell culture. The Electrospinning Company has a range of materials in development for use in 3D cell expansion in bioreactors, for example to increase the efficiency of the manufacture of stem cells for… Read more »
ELRIG Drug Discovery – Liverpool – 3rd-4th October
Drug Discovery is ELRIG’s flagship event. Now in its 11th year, we return to ACC in Liverpool to bring together the leading lights in drug discovery research across pharma, biotech, academia and the vendor community. CEO Ann Kramer and production technician Stephen Jones will attend on behalf of The Electrospinning Company. Please contact firstname.lastname@example.org if… Read more »
Eye on the future
An interview in the Education Times of India with Professor MacNeil describing corneal damage and repair research. In an article published on 31 May 2017, Sheila MacNeil, professor of tissue engineering, department of materials science & engineering, Kroto Research Institute University of Sheffield, UK, speaks to Ruchi Chopda on the status of corneal damage treatment… Read more »
Muscle progenitor stem cells in 3D maintain character after expansion in Mimetix scaffolds
CD133+ progenitor stem cells were shown to maintain ‘stem-ness’ after expansion in Mimetix 3D cell culture. In a recent publication in the Journal of Biomaterials and Tissue Engineering, researchers at KTH in Sweden characterised the growth and differentiation of CD133+ stem cells in Mimetix 3D and in conventional 2D cell culture. CD133+ cells are myogenic progenitors… Read more »